When it comes to product innovation in cannabis, it is essential to keep science at the forefront to ensure quality and consistent experiences. Considering how numerous patients and consumers use cannabis in their daily routines, it is vital to fully leverage existing cannabinoid research and the expertise of cannabis scientists during the R&D process. In this episode, Ari Mackler, chief product officer at PLUS Products, discusses how his expansive background in science, academia and medicine prepared him to bring evidence-based approaches to cannabis product innovation. He explains how PLUS uses science to define its products and emphasizes the need for further clinical research to enhance the industry’s scientific understanding of cannabis.